| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Endothelial Growth Factor A | 26 | 2025 | 215 | 5.450 |
Why?
|
| Breast Neoplasms | 43 | 2025 | 1211 | 5.350 |
Why?
|
| Integrin beta4 | 17 | 2024 | 35 | 5.270 |
Why?
|
| Neuropilin-2 | 12 | 2024 | 40 | 5.110 |
Why?
|
| Triple Negative Breast Neoplasms | 8 | 2025 | 73 | 4.540 |
Why?
|
| Integrins | 47 | 2016 | 109 | 4.440 |
Why?
|
| Integrin alpha6beta4 | 35 | 2018 | 44 | 4.060 |
Why?
|
| Signal Transduction | 50 | 2025 | 3070 | 3.550 |
Why?
|
| Gene Expression Regulation, Neoplastic | 22 | 2025 | 534 | 3.480 |
Why?
|
| Cell Line, Tumor | 43 | 2025 | 1494 | 3.360 |
Why?
|
| Neoplastic Stem Cells | 13 | 2020 | 199 | 2.660 |
Why?
|
| Carcinoma | 16 | 2019 | 129 | 2.600 |
Why?
|
| Antigens, Surface | 22 | 2002 | 199 | 2.320 |
Why?
|
| Integrin alpha6beta1 | 18 | 2015 | 34 | 2.310 |
Why?
|
| Laminin | 32 | 2015 | 78 | 2.160 |
Why?
|
| Neoplasm Invasiveness | 29 | 2016 | 278 | 2.090 |
Why?
|
| Transcription Factors | 16 | 2019 | 1540 | 2.080 |
Why?
|
| Epithelial Cells | 14 | 2019 | 401 | 2.050 |
Why?
|
| Estrogen Receptor beta | 5 | 2015 | 24 | 2.000 |
Why?
|
| Cell Movement | 32 | 2025 | 466 | 1.950 |
Why?
|
| Neoplasms | 17 | 2024 | 1392 | 1.930 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 421 | 1.920 |
Why?
|
| Mammary Glands, Animal | 6 | 2019 | 79 | 1.840 |
Why?
|
| Colonic Neoplasms | 21 | 2006 | 221 | 1.830 |
Why?
|
| B7-H1 Antigen | 3 | 2024 | 59 | 1.760 |
Why?
|
| Extracellular Matrix | 13 | 2019 | 139 | 1.740 |
Why?
|
| Neoplasm Proteins | 11 | 2024 | 283 | 1.680 |
Why?
|
| Cell Adhesion | 33 | 2018 | 212 | 1.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2024 | 431 | 1.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2018 | 343 | 1.340 |
Why?
|
| Animals | 83 | 2025 | 20961 | 1.310 |
Why?
|
| Humans | 137 | 2025 | 64238 | 1.300 |
Why?
|
| Cell Transformation, Neoplastic | 10 | 2015 | 207 | 1.290 |
Why?
|
| Mesoderm | 9 | 2010 | 85 | 1.280 |
Why?
|
| Biomarkers, Tumor | 13 | 2015 | 512 | 1.270 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2025 | 201 | 1.270 |
Why?
|
| Iron | 3 | 2019 | 154 | 1.240 |
Why?
|
| Mice | 56 | 2025 | 11003 | 1.180 |
Why?
|
| RNA-Binding Proteins | 6 | 2015 | 443 | 1.170 |
Why?
|
| TRPC6 Cation Channel | 2 | 2025 | 8 | 1.160 |
Why?
|
| Radiation Tolerance | 2 | 2025 | 56 | 1.140 |
Why?
|
| Neovascularization, Pathologic | 5 | 2019 | 141 | 1.120 |
Why?
|
| Apoptosis | 14 | 2018 | 1094 | 1.120 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2025 | 31 | 1.090 |
Why?
|
| Integrin beta1 | 4 | 2025 | 32 | 1.070 |
Why?
|
| Neoplasm Metastasis | 10 | 2025 | 210 | 1.050 |
Why?
|
| Cell Adhesion Molecules | 6 | 2024 | 92 | 1.050 |
Why?
|
| Phosphoproteins | 4 | 2024 | 221 | 1.040 |
Why?
|
| Tumor Cells, Cultured | 31 | 2018 | 460 | 1.030 |
Why?
|
| Transcription, Genetic | 11 | 2018 | 883 | 1.010 |
Why?
|
| Vascular Endothelial Growth Factors | 6 | 2019 | 21 | 0.990 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2015 | 34 | 0.980 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 666 | 0.950 |
Why?
|
| GATA3 Transcription Factor | 1 | 2025 | 17 | 0.930 |
Why?
|
| Female | 57 | 2025 | 33350 | 0.920 |
Why?
|
| Integrin alpha6 | 6 | 2023 | 20 | 0.900 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2018 | 16 | 0.860 |
Why?
|
| Neuropilins | 3 | 2019 | 8 | 0.850 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2024 | 8 | 0.850 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2023 | 10 | 0.820 |
Why?
|
| Cell Line | 22 | 2019 | 2055 | 0.820 |
Why?
|
| Nitric Oxide | 1 | 2024 | 174 | 0.810 |
Why?
|
| Neuropilin-1 | 5 | 2023 | 12 | 0.780 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2016 | 62 | 0.780 |
Why?
|
| rhoA GTP-Binding Protein | 6 | 2006 | 27 | 0.780 |
Why?
|
| Coenzyme A Ligases | 2 | 2025 | 13 | 0.770 |
Why?
|
| Oxidative Stress | 1 | 2024 | 304 | 0.760 |
Why?
|
| Autocrine Communication | 4 | 2013 | 30 | 0.760 |
Why?
|
| RNA | 2 | 2025 | 429 | 0.740 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 355 | 0.740 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 77 | 0.710 |
Why?
|
| Antigens, Neoplasm | 8 | 2005 | 136 | 0.700 |
Why?
|
| Ultracentrifugation | 1 | 2021 | 28 | 0.680 |
Why?
|
| Membrane Glycoproteins | 6 | 2019 | 671 | 0.680 |
Why?
|
| RNA, Messenger | 15 | 2023 | 1551 | 0.670 |
Why?
|
| Cell Separation | 1 | 2021 | 146 | 0.660 |
Why?
|
| Macrophages | 13 | 1998 | 1053 | 0.660 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 46 | 0.650 |
Why?
|
| Antigens, CD | 7 | 2002 | 348 | 0.650 |
Why?
|
| Protein Kinase C | 7 | 2012 | 103 | 0.630 |
Why?
|
| Chemotaxis | 7 | 2004 | 49 | 0.630 |
Why?
|
| Endothelial Growth Factors | 4 | 2003 | 22 | 0.610 |
Why?
|
| Lymphokines | 4 | 2003 | 67 | 0.610 |
Why?
|
| Colorectal Neoplasms | 6 | 2007 | 276 | 0.610 |
Why?
|
| Breast | 4 | 2018 | 190 | 0.600 |
Why?
|
| Rad51 Recombinase | 1 | 2019 | 29 | 0.600 |
Why?
|
| src-Family Kinases | 2 | 2017 | 64 | 0.590 |
Why?
|
| Cadherins | 8 | 2013 | 82 | 0.590 |
Why?
|
| Protein Binding | 12 | 2023 | 1618 | 0.590 |
Why?
|
| RNA Interference | 10 | 2015 | 618 | 0.580 |
Why?
|
| Receptors, Laminin | 13 | 2000 | 17 | 0.570 |
Why?
|
| Actins | 7 | 2005 | 261 | 0.560 |
Why?
|
| Histones | 2 | 2013 | 486 | 0.550 |
Why?
|
| Wnt Proteins | 1 | 2018 | 100 | 0.550 |
Why?
|
| NF-kappa B | 4 | 2015 | 471 | 0.540 |
Why?
|
| Glutathione Peroxidase | 1 | 2017 | 29 | 0.540 |
Why?
|
| MicroRNAs | 4 | 2025 | 697 | 0.540 |
Why?
|
| Stem Cells | 1 | 2019 | 262 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 329 | 0.530 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2015 | 85 | 0.530 |
Why?
|
| Trans-Activators | 4 | 2024 | 312 | 0.530 |
Why?
|
| Cell Survival | 10 | 2016 | 582 | 0.520 |
Why?
|
| Phosphatidylinositol 3-Kinases | 11 | 2008 | 174 | 0.510 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 364 | 0.500 |
Why?
|
| Cytoskeleton | 8 | 2003 | 139 | 0.500 |
Why?
|
| Snail Family Transcription Factors | 5 | 2018 | 28 | 0.500 |
Why?
|
| Epithelium | 6 | 2007 | 96 | 0.490 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2025 | 309 | 0.490 |
Why?
|
| Polycomb Repressive Complex 1 | 2 | 2014 | 31 | 0.480 |
Why?
|
| RNA, Small Interfering | 11 | 2014 | 927 | 0.480 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2015 | 9 | 0.470 |
Why?
|
| Enzyme Activation | 10 | 2012 | 386 | 0.470 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2006 | 19 | 0.460 |
Why?
|
| Transfection | 19 | 2006 | 695 | 0.460 |
Why?
|
| Focal Adhesions | 2 | 2012 | 24 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2025 | 110 | 0.450 |
Why?
|
| Gene Editing | 1 | 2019 | 324 | 0.450 |
Why?
|
| Lipid Peroxidation | 3 | 2021 | 65 | 0.450 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 4 | 2019 | 33 | 0.430 |
Why?
|
| Protein Biosynthesis | 4 | 2012 | 329 | 0.420 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 1621 | 0.420 |
Why?
|
| Intestinal Mucosa | 6 | 2005 | 243 | 0.420 |
Why?
|
| Basement Membrane | 7 | 2001 | 25 | 0.410 |
Why?
|
| Immunohistochemistry | 14 | 2014 | 901 | 0.410 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2013 | 3 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 132 | 0.410 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2013 | 6 | 0.400 |
Why?
|
| Organoids | 3 | 2003 | 45 | 0.400 |
Why?
|
| Mice, Knockout | 8 | 2019 | 2140 | 0.390 |
Why?
|
| Response Elements | 1 | 2013 | 44 | 0.390 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 37 | 0.390 |
Why?
|
| RNA Splicing | 1 | 2014 | 164 | 0.390 |
Why?
|
| Disease Progression | 11 | 2012 | 1176 | 0.390 |
Why?
|
| ErbB Receptors | 2 | 2012 | 120 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 15 | 2019 | 3450 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 544 | 0.380 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 30 | 0.370 |
Why?
|
| Osteonectin | 1 | 2012 | 2 | 0.370 |
Why?
|
| Cell Differentiation | 8 | 2020 | 1365 | 0.370 |
Why?
|
| Wound Healing | 3 | 2014 | 192 | 0.360 |
Why?
|
| Antigens, Differentiation | 5 | 1997 | 141 | 0.360 |
Why?
|
| BRCA1 Protein | 2 | 2025 | 58 | 0.360 |
Why?
|
| Piperazines | 3 | 2024 | 87 | 0.360 |
Why?
|
| DNA-Binding Proteins | 8 | 2025 | 1196 | 0.350 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 129 | 0.350 |
Why?
|
| Immunoblotting | 7 | 2015 | 206 | 0.350 |
Why?
|
| Morphogenesis | 2 | 2011 | 114 | 0.350 |
Why?
|
| Transforming Growth Factor beta | 6 | 2010 | 174 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 7 | 2014 | 674 | 0.330 |
Why?
|
| Cyclic AMP | 3 | 2001 | 145 | 0.330 |
Why?
|
| Membrane Proteins | 10 | 2011 | 909 | 0.330 |
Why?
|
| Molecular Sequence Data | 14 | 2016 | 1997 | 0.320 |
Why?
|
| ras Proteins | 3 | 2006 | 77 | 0.320 |
Why?
|
| Binding Sites | 6 | 2018 | 914 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 2 | 2003 | 429 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 3 | 1995 | 205 | 0.310 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 15 | 0.300 |
Why?
|
| Microtubules | 3 | 2005 | 210 | 0.300 |
Why?
|
| Colon | 4 | 2003 | 149 | 0.300 |
Why?
|
| Ligands | 6 | 2015 | 417 | 0.300 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 783 | 0.290 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 1297 | 0.290 |
Why?
|
| Tumor Microenvironment | 5 | 2025 | 162 | 0.290 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2007 | 153 | 0.290 |
Why?
|
| Receptors, Immunologic | 5 | 1992 | 179 | 0.290 |
Why?
|
| Prognosis | 8 | 2015 | 1769 | 0.280 |
Why?
|
| DNA Methylation | 2 | 2014 | 294 | 0.280 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2005 | 46 | 0.280 |
Why?
|
| Lysosomes | 2 | 2008 | 169 | 0.280 |
Why?
|
| Cell Hypoxia | 4 | 2015 | 42 | 0.270 |
Why?
|
| Lectins | 3 | 1993 | 41 | 0.270 |
Why?
|
| Integrin alpha5 | 2 | 2005 | 7 | 0.270 |
Why?
|
| Carrier Proteins | 4 | 2008 | 709 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 644 | 0.270 |
Why?
|
| Fibronectins | 7 | 2020 | 43 | 0.270 |
Why?
|
| Base Sequence | 11 | 2016 | 1332 | 0.260 |
Why?
|
| Receptor, ErbB-3 | 1 | 2007 | 2 | 0.260 |
Why?
|
| Hemidesmosomes | 2 | 2004 | 6 | 0.260 |
Why?
|
| Cytoplasm | 8 | 2005 | 279 | 0.260 |
Why?
|
| Phosphorylation | 9 | 2005 | 948 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2005 | 616 | 0.250 |
Why?
|
| Hyaluronan Receptors | 2 | 2019 | 35 | 0.250 |
Why?
|
| Calcium | 6 | 2023 | 580 | 0.250 |
Why?
|
| E2F Transcription Factors | 1 | 2006 | 16 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2007 | 210 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2005 | 217 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 8 | 2023 | 870 | 0.240 |
Why?
|
| Integrin beta3 | 1 | 2025 | 9 | 0.240 |
Why?
|
| Microscopy, Video | 3 | 2019 | 38 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 5 | 2014 | 685 | 0.240 |
Why?
|
| Male | 17 | 2025 | 30294 | 0.240 |
Why?
|
| Pseudopodia | 3 | 2001 | 13 | 0.230 |
Why?
|
| Amino Acid Sequence | 12 | 2015 | 1597 | 0.230 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 18 | 0.230 |
Why?
|
| Glutathione | 1 | 2025 | 56 | 0.230 |
Why?
|
| Protein Stability | 2 | 2018 | 93 | 0.230 |
Why?
|
| Genetic Variation | 4 | 1995 | 387 | 0.230 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 526 | 0.230 |
Why?
|
| Macrophage Activation | 5 | 1993 | 119 | 0.230 |
Why?
|
| Sucrase-Isomaltase Complex | 4 | 1997 | 4 | 0.230 |
Why?
|
| Integrin beta Chains | 1 | 2005 | 2 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2176 | 0.230 |
Why?
|
| Metalloendopeptidases | 5 | 2005 | 21 | 0.220 |
Why?
|
| Desmosomes | 3 | 2005 | 7 | 0.220 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2025 | 23 | 0.220 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2004 | 3 | 0.220 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2024 | 13 | 0.220 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2025 | 182 | 0.220 |
Why?
|
| Models, Biological | 7 | 2016 | 1187 | 0.220 |
Why?
|
| Imidazoles | 1 | 2024 | 84 | 0.220 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 19 | 0.220 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 79 | 0.210 |
Why?
|
| Interleukin-8 | 1 | 2004 | 92 | 0.210 |
Why?
|
| Immunoconjugates | 1 | 2024 | 93 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2024 | 71 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 7 | 2010 | 518 | 0.210 |
Why?
|
| Up-Regulation | 2 | 2014 | 375 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2018 | 1001 | 0.210 |
Why?
|
| Transcriptional Activation | 3 | 2012 | 191 | 0.210 |
Why?
|
| Homologous Recombination | 2 | 2025 | 28 | 0.210 |
Why?
|
| TRPC Cation Channels | 1 | 2023 | 13 | 0.210 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2023 | 9 | 0.210 |
Why?
|
| Cell Aggregation | 4 | 2018 | 21 | 0.210 |
Why?
|
| Semaphorin-3A | 1 | 2003 | 5 | 0.210 |
Why?
|
| RNA, Neoplasm | 3 | 2013 | 34 | 0.200 |
Why?
|
| Flow Cytometry | 4 | 2021 | 668 | 0.200 |
Why?
|
| HEK293 Cells | 2 | 2018 | 627 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 36 | 0.200 |
Why?
|
| Nanoparticles | 2 | 2020 | 523 | 0.200 |
Why?
|
| Cell Communication | 3 | 2021 | 132 | 0.200 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2003 | 7 | 0.200 |
Why?
|
| Calcium Channels | 1 | 2023 | 103 | 0.200 |
Why?
|
| Alternative Splicing | 3 | 2019 | 130 | 0.200 |
Why?
|
| Genes, ras | 1 | 2003 | 27 | 0.200 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 430 | 0.190 |
Why?
|
| Receptors, CXCR4 | 1 | 2002 | 37 | 0.190 |
Why?
|
| Enzyme Inhibitors | 5 | 2008 | 373 | 0.190 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 33 | 0.190 |
Why?
|
| Hemagglutinins | 2 | 1991 | 17 | 0.180 |
Why?
|
| NIH 3T3 Cells | 3 | 2007 | 100 | 0.180 |
Why?
|
| Cell Membrane | 6 | 2008 | 501 | 0.180 |
Why?
|
| Tyrosine | 2 | 2007 | 94 | 0.180 |
Why?
|
| Cell Polarity | 1 | 2022 | 109 | 0.180 |
Why?
|
| DNA, Complementary | 7 | 2002 | 165 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 63 | 0.170 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 94 | 0.170 |
Why?
|
| Immunologic Tests | 1 | 2021 | 5 | 0.170 |
Why?
|
| Collagen | 6 | 2006 | 124 | 0.170 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1995 | 66 | 0.170 |
Why?
|
| Neuropeptides | 1 | 2001 | 81 | 0.170 |
Why?
|
| Gene Deletion | 3 | 2015 | 312 | 0.170 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 67 | 0.170 |
Why?
|
| I-kappa B Kinase | 2 | 2015 | 50 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 136 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2021 | 61 | 0.160 |
Why?
|
| Proteins | 2 | 2004 | 760 | 0.160 |
Why?
|
| Muscle Proteins | 2 | 2016 | 117 | 0.160 |
Why?
|
| Biological Transport | 1 | 2021 | 291 | 0.160 |
Why?
|
| Gene Silencing | 1 | 2003 | 405 | 0.160 |
Why?
|
| Multivesicular Bodies | 1 | 2019 | 5 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2003 | 410 | 0.160 |
Why?
|
| Cluster Analysis | 3 | 2016 | 263 | 0.160 |
Why?
|
| Ferritins | 1 | 2019 | 31 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2007 | 43 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2007 | 46 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 183 | 0.160 |
Why?
|
| Receptors, Progesterone | 2 | 2012 | 110 | 0.160 |
Why?
|
| Platinum | 1 | 2019 | 20 | 0.150 |
Why?
|
| Indoles | 2 | 2016 | 115 | 0.150 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 130 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 239 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 195 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2013 | 112 | 0.150 |
Why?
|
| Acyltransferases | 1 | 2018 | 33 | 0.140 |
Why?
|
| Nectins | 1 | 2018 | 3 | 0.140 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2018 | 3 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2018 | 517 | 0.140 |
Why?
|
| ADAM Proteins | 6 | 2011 | 32 | 0.140 |
Why?
|
| Photoreceptor Cells | 4 | 1982 | 19 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 34 | 0.140 |
Why?
|
| Culture Media, Conditioned | 3 | 2004 | 52 | 0.140 |
Why?
|
| Epidermal Growth Factor | 3 | 2004 | 47 | 0.130 |
Why?
|
| Lysophospholipids | 3 | 2004 | 26 | 0.130 |
Why?
|
| DNA Repair | 1 | 2019 | 250 | 0.130 |
Why?
|
| Phenotype | 5 | 2018 | 1222 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 259 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 72 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 237 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2018 | 193 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2010 | 260 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2007 | 495 | 0.130 |
Why?
|
| Mice, Nude | 5 | 2011 | 281 | 0.130 |
Why?
|
| Leukocytes | 1 | 1997 | 103 | 0.130 |
Why?
|
| Endothelium, Vascular | 3 | 2008 | 176 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 128 | 0.120 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 240 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 396 | 0.120 |
Why?
|
| Dimerization | 3 | 2007 | 146 | 0.120 |
Why?
|
| Protein Kinase C-alpha | 3 | 2004 | 16 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 93 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 1 | 2016 | 41 | 0.120 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2015 | 27 | 0.120 |
Why?
|
| Bevacizumab | 1 | 2016 | 58 | 0.120 |
Why?
|
| rhoC GTP-Binding Protein | 2 | 2006 | 3 | 0.120 |
Why?
|
| Pyrroles | 1 | 2016 | 52 | 0.120 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 39 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 143 | 0.120 |
Why?
|
| Cyclins | 1 | 1995 | 42 | 0.120 |
Why?
|
| Recombinant Proteins | 4 | 2004 | 704 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 50 | 0.120 |
Why?
|
| Proteolysis | 2 | 2015 | 149 | 0.120 |
Why?
|
| Organ Size | 1 | 2015 | 169 | 0.110 |
Why?
|
| DNA Primers | 5 | 2003 | 295 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 76 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2015 | 22 | 0.110 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 306 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2015 | 21 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 13 | 0.110 |
Why?
|
| 3T3 Cells | 3 | 2004 | 112 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2011 | 63 | 0.110 |
Why?
|
| Carcinogenesis | 1 | 2016 | 131 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 2 | 2004 | 9 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 423 | 0.110 |
Why?
|
| Precipitin Tests | 5 | 2004 | 77 | 0.110 |
Why?
|
| CD24 Antigen | 1 | 2014 | 18 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2004 | 248 | 0.110 |
Why?
|
| Hominidae | 1 | 1994 | 7 | 0.110 |
Why?
|
| DNA | 3 | 1993 | 844 | 0.110 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 27 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2013 | 16 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 34 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 4 | 2002 | 402 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 391 | 0.100 |
Why?
|
| Glycolipids | 2 | 1984 | 47 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 60 | 0.100 |
Why?
|
| Hydroxylation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 11 | 0.100 |
Why?
|
| Mitoxantrone | 1 | 2013 | 16 | 0.100 |
Why?
|
| Galectin 3 | 5 | 1997 | 7 | 0.100 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2013 | 31 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 1993 | 24 | 0.100 |
Why?
|
| Lysine | 1 | 2013 | 87 | 0.100 |
Why?
|
| Methylation | 1 | 2013 | 131 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 68 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 891 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 38 | 0.100 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Cysteine | 2 | 2002 | 108 | 0.100 |
Why?
|
| Retina | 3 | 1982 | 126 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2013 | 101 | 0.100 |
Why?
|
| CpG Islands | 2 | 2014 | 216 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 68 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 297 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 231 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 1993 | 112 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2011 | 46 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2011 | 29 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 16 | 0.090 |
Why?
|
| Survival Rate | 3 | 2004 | 859 | 0.090 |
Why?
|
| Antibodies | 3 | 2002 | 186 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 83 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 386 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2004 | 785 | 0.090 |
Why?
|
| Intestinal Polyps | 1 | 1990 | 6 | 0.080 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2010 | 3 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2012 | 224 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 146 | 0.080 |
Why?
|
| Multienzyme Complexes | 1 | 1990 | 88 | 0.080 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 38 | 0.080 |
Why?
|
| Luciferases | 1 | 2010 | 108 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 94 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 365 | 0.080 |
Why?
|
| Caspases | 2 | 2001 | 176 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 1993 | 632 | 0.080 |
Why?
|
| Microscopy, Electron | 4 | 2001 | 251 | 0.080 |
Why?
|
| Integrin alpha3beta1 | 2 | 2000 | 3 | 0.070 |
Why?
|
| Proteoglycans | 2 | 2006 | 32 | 0.070 |
Why?
|
| Chloroquine | 1 | 2008 | 61 | 0.070 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2008 | 51 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 55 | 0.070 |
Why?
|
| Macrolides | 1 | 2008 | 38 | 0.070 |
Why?
|
| Keratin-6 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Keratin-5 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 4 | 1982 | 175 | 0.070 |
Why?
|
| Adenine | 1 | 2008 | 50 | 0.070 |
Why?
|
| Culture Media | 1 | 2008 | 79 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 1998 | 10 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2006 | 168 | 0.070 |
Why?
|
| Intercellular Junctions | 2 | 2005 | 8 | 0.070 |
Why?
|
| Sirolimus | 1 | 2008 | 94 | 0.070 |
Why?
|
| Galactosyltransferases | 1 | 1987 | 16 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2001 | 150 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2007 | 7 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2008 | 125 | 0.070 |
Why?
|
| Epitopes | 2 | 1999 | 292 | 0.070 |
Why?
|
| Gene Expression | 4 | 2011 | 851 | 0.070 |
Why?
|
| Rectal Neoplasms | 3 | 1995 | 128 | 0.070 |
Why?
|
| Hypoxia | 1 | 2008 | 116 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2007 | 1 | 0.070 |
Why?
|
| Neuregulin-1 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Chromatography, Affinity | 3 | 1992 | 49 | 0.070 |
Why?
|
| Retroviridae | 2 | 2004 | 74 | 0.060 |
Why?
|
| Membrane Lipids | 2 | 1984 | 28 | 0.060 |
Why?
|
| Sequence Deletion | 3 | 2000 | 116 | 0.060 |
Why?
|
| Stromal Cells | 3 | 2011 | 69 | 0.060 |
Why?
|
| Inflammation | 2 | 2002 | 1162 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 1989 | 576 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2019 | 199 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2006 | 4 | 0.060 |
Why?
|
| ADAM12 Protein | 4 | 2011 | 4 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 128 | 0.060 |
Why?
|
| Autophagy | 1 | 2008 | 231 | 0.060 |
Why?
|
| Catenins | 1 | 2005 | 14 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 1989 | 624 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 1986 | 78 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2025 | 22 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2011 | 36 | 0.060 |
Why?
|
| Glycoproteins | 2 | 1987 | 189 | 0.060 |
Why?
|
| Amino Sugars | 1 | 1985 | 2 | 0.060 |
Why?
|
| Glucose | 1 | 2008 | 470 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2005 | 33 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 21 | 0.060 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2025 | 14 | 0.060 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2025 | 18 | 0.060 |
Why?
|
| alpha Catenin | 2 | 1995 | 3 | 0.060 |
Why?
|
| Lactosylceramides | 1 | 1984 | 2 | 0.060 |
Why?
|
| Intracellular Membranes | 2 | 1982 | 50 | 0.060 |
Why?
|
| Time Factors | 3 | 2011 | 3724 | 0.060 |
Why?
|
| ADP Ribose Transferases | 1 | 2004 | 63 | 0.060 |
Why?
|
| Manganese | 2 | 1995 | 22 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2004 | 7 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2004 | 18 | 0.050 |
Why?
|
| Mutation | 1 | 2013 | 2629 | 0.050 |
Why?
|
| Peptide Mapping | 1 | 2004 | 29 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2002 | 135 | 0.050 |
Why?
|
| COS Cells | 1 | 2004 | 174 | 0.050 |
Why?
|
| Uridine Diphosphate Xylose | 1 | 2023 | 6 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 91 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2004 | 68 | 0.050 |
Why?
|
| Polysaccharides | 1 | 1985 | 151 | 0.050 |
Why?
|
| Neoplasm Transplantation | 3 | 2005 | 167 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 21 | 0.050 |
Why?
|
| Cell Size | 2 | 2003 | 41 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 1993 | 59 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2025 | 265 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2004 | 153 | 0.050 |
Why?
|
| Molecular Weight | 3 | 1993 | 190 | 0.050 |
Why?
|
| Cell Compartmentation | 2 | 2000 | 36 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 7 | 0.050 |
Why?
|
| Chemokine CXCL12 | 1 | 2002 | 18 | 0.050 |
Why?
|
| Biotinylation | 1 | 2003 | 36 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 29 | 0.050 |
Why?
|
| Cytokines | 1 | 2007 | 944 | 0.050 |
Why?
|
| Oncogene Proteins v-abl | 1 | 2002 | 1 | 0.050 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 1 | 0.050 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 15 | 0.050 |
Why?
|
| Polyribosomes | 1 | 2002 | 16 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 152 | 0.050 |
Why?
|
| Glycerol | 1 | 1982 | 33 | 0.050 |
Why?
|
| RNA, Bacterial | 1 | 2002 | 74 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 244 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1997 | 234 | 0.050 |
Why?
|
| Cell Division | 3 | 2002 | 454 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2001 | 1 | 0.040 |
Why?
|
| Chromones | 1 | 2001 | 19 | 0.040 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2001 | 7 | 0.040 |
Why?
|
| Anoikis | 1 | 2001 | 7 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 41 | 0.040 |
Why?
|
| Peptide Library | 1 | 2001 | 37 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 67 | 0.040 |
Why?
|
| Morpholines | 1 | 2001 | 90 | 0.040 |
Why?
|
| Adipocytes | 1 | 2003 | 269 | 0.040 |
Why?
|
| Point Mutation | 1 | 2001 | 165 | 0.040 |
Why?
|
| Protein Transport | 1 | 2002 | 405 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 145 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 614 | 0.040 |
Why?
|
| Rheology | 3 | 1995 | 76 | 0.040 |
Why?
|
| Plasmids | 1 | 2001 | 293 | 0.040 |
Why?
|
| Integrin alpha5beta1 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Monocytes | 1 | 2002 | 356 | 0.040 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 29 | 0.040 |
Why?
|
| Dogs | 1 | 2001 | 332 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1999 | 44 | 0.040 |
Why?
|
| Phosphoserine | 1 | 1999 | 10 | 0.040 |
Why?
|
| Keratins | 1 | 1999 | 31 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 1999 | 24 | 0.040 |
Why?
|
| Carbazoles | 1 | 1999 | 14 | 0.040 |
Why?
|
| Caspase 3 | 1 | 1999 | 108 | 0.040 |
Why?
|
| Sperm-Ovum Interactions | 2 | 1999 | 43 | 0.040 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1998 | 2 | 0.040 |
Why?
|
| Adult | 4 | 2014 | 17116 | 0.040 |
Why?
|
| Rolipram | 1 | 1998 | 3 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1998 | 12 | 0.040 |
Why?
|
| Membranes | 1 | 1979 | 18 | 0.040 |
Why?
|
| Cricetinae | 3 | 2005 | 368 | 0.040 |
Why?
|
| Colforsin | 1 | 1998 | 24 | 0.040 |
Why?
|
| Pyrrolidinones | 1 | 1998 | 11 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1998 | 27 | 0.040 |
Why?
|
| Middle Aged | 4 | 2014 | 17898 | 0.040 |
Why?
|
| Vimentin | 1 | 1998 | 19 | 0.040 |
Why?
|
| Thioglycolates | 2 | 1989 | 7 | 0.040 |
Why?
|
| Aged | 4 | 2014 | 14648 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2000 | 463 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 5520 | 0.030 |
Why?
|
| Androstadienes | 1 | 1997 | 41 | 0.030 |
Why?
|
| Flavonoids | 1 | 1998 | 75 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 87 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2003 | 889 | 0.030 |
Why?
|
| In Vitro Techniques | 3 | 1999 | 490 | 0.030 |
Why?
|
| Isomerism | 1 | 1997 | 28 | 0.030 |
Why?
|
| Spermatozoa | 2 | 1999 | 261 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 695 | 0.030 |
Why?
|
| Kinetics | 1 | 1998 | 766 | 0.030 |
Why?
|
| Peritoneal Cavity | 2 | 1987 | 31 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1998 | 404 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1998 | 181 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2016 | 24 | 0.030 |
Why?
|
| Oligo-1,6-Glucosidase | 1 | 1995 | 1 | 0.030 |
Why?
|
| Sucrase | 1 | 1995 | 1 | 0.030 |
Why?
|
| Paxillin | 1 | 1995 | 9 | 0.030 |
Why?
|
| Pregnancy | 2 | 2012 | 2370 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1995 | 56 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1995 | 16 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 102 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1995 | 133 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 273 | 0.030 |
Why?
|
| Ovum | 1 | 1995 | 63 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 1995 | 110 | 0.030 |
Why?
|
| Systems Biology | 1 | 2015 | 34 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 41 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1995 | 340 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 196 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 79 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 529 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 182 | 0.030 |
Why?
|
| Clone Cells | 1 | 1994 | 116 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 104 | 0.030 |
Why?
|
| Nanostructures | 1 | 2016 | 181 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1994 | 89 | 0.030 |
Why?
|
| Neurons | 1 | 1980 | 934 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 240 | 0.030 |
Why?
|
| CHO Cells | 2 | 2005 | 189 | 0.030 |
Why?
|
| Placenta | 1 | 1994 | 61 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1995 | 396 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 324 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2015 | 151 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 58 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1994 | 385 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 209 | 0.020 |
Why?
|
| Chickens | 1 | 1993 | 94 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1993 | 68 | 0.020 |
Why?
|
| Rana pipiens | 2 | 1982 | 8 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 49 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2012 | 60 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 296 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 1992 | 76 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 385 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2238 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 249 | 0.020 |
Why?
|
| Synaptic Vesicles | 2 | 1982 | 25 | 0.020 |
Why?
|
| Axonal Transport | 2 | 1982 | 32 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1991 | 40 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 1990 | 24 | 0.020 |
Why?
|
| Cytosol | 1 | 1991 | 181 | 0.020 |
Why?
|
| Axons | 2 | 1982 | 126 | 0.020 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2010 | 3 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2010 | 17 | 0.020 |
Why?
|
| Synapses | 2 | 1982 | 191 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2010 | 13 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 540 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1990 | 40 | 0.020 |
Why?
|
| Endoribonucleases | 1 | 2010 | 56 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 126 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 230 | 0.020 |
Why?
|
| Anura | 2 | 1980 | 14 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 113 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 58 | 0.020 |
Why?
|
| Golgi Apparatus | 2 | 1980 | 64 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1989 | 33 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 46 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 183 | 0.020 |
Why?
|
| beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase | 1 | 1987 | 1 | 0.020 |
Why?
|
| Lactose Synthase | 1 | 1987 | 3 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 1987 | 10 | 0.020 |
Why?
|
| Galactose | 1 | 1987 | 13 | 0.020 |
Why?
|
| Fertilins | 2 | 1999 | 2 | 0.020 |
Why?
|
| Mice, Inbred ICR | 2 | 1999 | 33 | 0.020 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1986 | 2 | 0.020 |
Why?
|
| Glucosamine | 1 | 1986 | 31 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 2094 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1985 | 15 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1985 | 12 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1985 | 65 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1985 | 55 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 5 | 0.010 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2005 | 7 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 90 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1985 | 84 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2005 | 34 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 14 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 52 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1984 | 12 | 0.010 |
Why?
|
| G(M1) Ganglioside | 1 | 1984 | 12 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1984 | 19 | 0.010 |
Why?
|
| Galactosylceramides | 1 | 1984 | 11 | 0.010 |
Why?
|
| Glycosphingolipids | 1 | 1984 | 9 | 0.010 |
Why?
|
| Benzamides | 1 | 2005 | 66 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1986 | 268 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2005 | 146 | 0.010 |
Why?
|
| Stress Fibers | 1 | 2003 | 2 | 0.010 |
Why?
|
| Octoxynol | 1 | 2003 | 11 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2005 | 189 | 0.010 |
Why?
|
| Cricetulus | 1 | 2003 | 100 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2002 | 15 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 348 | 0.010 |
Why?
|
| Tumor Protein p73 | 1 | 2002 | 4 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 99 | 0.010 |
Why?
|
| Autoradiography | 1 | 1982 | 53 | 0.010 |
Why?
|
| Choline | 1 | 1982 | 23 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 72 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1982 | 53 | 0.010 |
Why?
|
| Leucine | 1 | 1982 | 67 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 166 | 0.010 |
Why?
|
| Phospholipids | 1 | 1982 | 82 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4776 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 204 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 1980 | 15 | 0.010 |
Why?
|
| Rod Cell Outer Segment | 1 | 1980 | 8 | 0.010 |
Why?
|
| Dendrites | 1 | 1980 | 61 | 0.010 |
Why?
|
| Disintegrins | 1 | 1999 | 4 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 2005 | 0.010 |
Why?
|
| Zygote | 1 | 1999 | 45 | 0.010 |
Why?
|
| Intermediate Filaments | 1 | 1998 | 10 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1979 | 45 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1998 | 71 | 0.010 |
Why?
|
| Endocytosis | 1 | 1979 | 153 | 0.010 |
Why?
|
| Movement | 1 | 1979 | 161 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 417 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1995 | 39 | 0.010 |
Why?
|
| Hemorheology | 1 | 1995 | 6 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1995 | 19 | 0.010 |
Why?
|
| E-Selectin | 1 | 1995 | 18 | 0.010 |
Why?
|
| Veins | 1 | 1995 | 64 | 0.010 |
Why?
|
| Arteries | 1 | 1995 | 80 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1995 | 735 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1995 | 930 | 0.010 |
Why?
|
| Immune Sera | 1 | 1990 | 35 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1992 | 107 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1995 | 2478 | 0.000 |
Why?
|
| Rabbits | 1 | 1990 | 333 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1987 | 109 | 0.000 |
Why?
|
| Risk Factors | 1 | 1995 | 5339 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1995 | 6726 | 0.000 |
Why?
|